Today we announced Q2 2024 financial results and recent business highlights. The results are available on our website: https://lnkd.in/gfigS8Q.
Edgewise Therapeutics
Biotechnology Research
Boulder, CO 10,365 followers
On a mission to improve the lives of people facing serious muscle disease.
About us
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.
- Website
-
https://edgewisetx.com/
External link for Edgewise Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boulder, CO
- Type
- Public Company
- Founded
- 2017
Locations
-
Primary
1715 38th St.
Boulder, CO 80301, US
Employees at Edgewise Therapeutics
-
Mike Carruthers
CFO Edgewise Therapeutics
-
Bruce D. Johnson
Pharmaceutical R&D Scientific Expertise Balanced with Business Acumen | Concept-to-Launch CMC Product Development | Collaborative Leader
-
Chris Dufton, PhD
Clinical Development and Operations Expert with +25 years of Clinical Research Experience
-
Behrad Derakhshan, PhD
Chief Business Officer at Edgewise Therapeutics
Updates
-
Join PPMD and Edgewise Therapeutics for a webinar on August 7th, 2024, at 1 PM ET to learn more about Edgewise’s ongoing clinical trials, which aim to protect muscle in individuals living with #Becker. This webinar will feature Edgewise’s Chief Scientific Officer and Chief Medical Officer, who will share two year results from the completed Phase 1 ARCH study in adults with Becker and more information about their current enrolling trial, GRAND CANYON, a phase 2 pivotal cohort for adults living with Becker. Learn more, register, and submit questions in advance: https://lnkd.in/edvKZnCW
-
We're leaders in muscle disease science. Our goal is to improve the lives of patients and families suffering from serious muscle diseases. Learn more about Edgewise at edgewisetx.com/company. #EdgewiseTherapeutics #RareMuscleDisease
-
-
We expect to report our Q2 2024 financial results and recent business highlights on Thursday, August 8 pre-market open. The results will be available on our website here: https://bit.ly/4dosM6r.
-
-
GRAND CANYON, a pivotal clinical study to evaluate an investigational drug in individuals living with #Becker #MuscularDystrophy is ongoing. Visit the study website to learn more: https://bit.ly/4bLeax2.
-
-
It was an honor to sponsor the Romito Foundation (Richard Romito) Farm to Table Experience at Balistreri Vineyards to raise awareness and support for members of the Duchenne community. Our team and other attendees enjoyed the evening, all while gathering for an incredible cause. Learn how the Romito family were inspired to begin their foundation here: https://lnkd.in/m09hc. Team pictured: Bruce D. Johnson, Ben Barthel, Angela Peter, Ph.D., Breanne Newell-Stamper, Sarah Lehman, Ph.D., Alan Russell, AJ Fosdick, Sarah Stoffel
-
-
We’re in Chicago this week for AHA’s Basic Cardiovascular Sciences meeting (#BCVS24). We’re honored to showcase preclinical data on EDG-7500, our novel, oral, selective sarcomere modulator for hypertrophic cardiomyopathy and other diseases of diastolic dysfunction. The poster will be on our website after it’s presented: https://lnkd.in/efKXPPDy
-
-
Did you know that 1 in 250 individuals have Hypertrophic Cardiomyopathy (HCM)? Unfamiliar with HCM? It’s a common form of inherited heart disease with symptoms including chest pains, fatigue, and shortness of breath. Learn more about our clinical development program in HCM by visiting: https://lnkd.in/e36v5Y5s.
-
-
We are driven by urgency and inspired by passion and courage. Together, we are pioneering the development of medicines for rare muscle disorders. Edgewise Therapeutics offers excellent benefits, including competitive compensation packages, comprehensive health benefits, and a robust PTO plan. Explore career openings at https://lnkd.in/gV3xSsSZ.
-
-
Join us for a day all about Becker! This year’s topics include mental wellness, exercise & physical therapy, planning for the future and much more. Register today! Don’t miss out! For details and registration, visit https://lnkd.in/e4H3d2nF. #Becker #BeckerEducation #EdgewiseTherapeutics
-